CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,622,000 | +448.2% | 128,181 | +162.9% | 0.01% | +600.0% |
| Q2 2022 | $1,208,000 | -1.9% | 48,763 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $1,231,000 | -32.2% | 49,083 | -1.6% | 0.00% | 0.0% |
| Q4 2021 | $1,816,000 | +70.4% | 49,876 | -20.0% | 0.00% | 0.0% |
| Q3 2021 | $1,066,000 | +99.6% | 62,341 | +56.3% | 0.00% | – |
| Q2 2021 | $534,000 | -76.9% | 39,890 | -11.5% | 0.00% | -100.0% |
| Q1 2021 | $2,308,000 | -55.5% | 45,051 | -46.2% | 0.00% | -66.7% |
| Q4 2020 | $5,183,000 | +43.9% | 83,683 | +27.3% | 0.00% | +50.0% |
| Q3 2020 | $3,601,000 | -11.8% | 65,713 | -7.4% | 0.00% | -33.3% |
| Q2 2020 | $4,084,000 | +365.1% | 70,951 | +224.5% | 0.00% | +200.0% |
| Q1 2020 | $878,000 | -17.9% | 21,865 | -19.1% | 0.00% | 0.0% |
| Q4 2019 | $1,069,000 | +790.8% | 27,043 | +53.2% | 0.00% | – |
| Q3 2019 | $120,000 | -27.7% | 17,650 | -1.0% | 0.00% | – |
| Q2 2019 | $166,000 | -8.3% | 17,832 | +36.6% | 0.00% | – |
| Q1 2019 | $181,000 | +58.8% | 13,053 | +25.3% | 0.00% | – |
| Q4 2018 | $114,000 | -39.0% | 10,418 | -27.0% | 0.00% | – |
| Q2 2018 | $187,000 | +3.9% | 14,279 | +7.6% | 0.00% | – |
| Q1 2018 | $180,000 | +168.7% | 13,269 | +17.2% | 0.00% | – |
| Q4 2017 | $67,000 | -50.0% | 11,325 | -37.2% | 0.00% | – |
| Q3 2017 | $134,000 | -32.3% | 18,040 | -32.8% | 0.00% | – |
| Q4 2016 | $198,000 | +53.5% | 26,835 | +25.6% | 0.00% | – |
| Q3 2016 | $129,000 | -12.8% | 21,360 | -35.2% | 0.00% | – |
| Q2 2016 | $148,000 | -92.2% | 32,981 | -95.7% | 0.00% | -100.0% |
| Q1 2016 | $1,907,000 | -52.4% | 765,996 | +54.9% | 0.00% | -60.0% |
| Q4 2015 | $4,007,000 | +479.9% | 494,612 | +333.5% | 0.01% | +400.0% |
| Q3 2015 | $691,000 | +67.3% | 114,106 | +127.4% | 0.00% | – |
| Q2 2015 | $413,000 | +103.4% | 50,177 | +85.9% | 0.00% | – |
| Q1 2015 | $203,000 | -38.1% | 26,985 | -43.9% | 0.00% | – |
| Q4 2014 | $328,000 | +241.7% | 48,111 | +125.9% | 0.00% | – |
| Q3 2014 | $96,000 | -19.3% | 21,295 | +4.0% | 0.00% | – |
| Q2 2014 | $119,000 | -58.8% | 20,469 | -52.9% | 0.00% | – |
| Q1 2014 | $289,000 | -39.3% | 43,433 | -47.2% | 0.00% | – |
| Q4 2013 | $476,000 | -47.6% | 82,334 | -49.7% | 0.00% | -100.0% |
| Q3 2013 | $909,000 | +168.9% | 163,537 | +585.3% | 0.00% | – |
| Q2 2013 | $338,000 | – | 23,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |